Ticker Details
Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
IPO Date:	March 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.32B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 3.93%
Avg Daily Range (30 D):	$0.82 | 3.05%
Avg Daily Range (90 D):	$0.45 | 3.67%

Institutional Daily Volume
Avg Daily Volume:	.7M
Avg Daily Volume (30 D):	1.78M
Avg Daily Volume (90 D):	2.18M

Trade Size
Avg Trade Size (Sh.):	172
Avg Trade Size (Sh.) (30 D):	91
Avg Trade Size (Sh.) (90 D):	110

Institutional Trades
Total Institutional Trades:	464
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$1.72M
Avg Institutional Trade (90 D):	$1.87M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.63M
Avg Closing Trade (30 D):	$2.69M
Avg Closing Trade (90 D):	$2.68M
Avg Closing Volume:	126.71K

News

Dec 3, 2025 @ 7:21 PM Capricor Stock Soars, Shkreli Is Short: Here's Wha... Source: Erica Kollmann

Sep 25, 2025 @ 3:16 PM Why Capricor Therapeutics Stock Is Surging Today Source: Alex Perry

Sep 15, 2025 @ 7:58 PM Shareholders of Capricor Therapeutics, Inc. Should... Source: The Gross Law Firm

Sep 14, 2025 @ 8:00 PM CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc

Sep 14, 2025 @ 1:44 PM CAPR IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR C... Source: Rosen Law Firm

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.54	$-.57	$-.53
Diluted EPS	$-.54	$-.57	$-.53
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-24.57M	$-25.91M	$-24.39M
Operating Income / Loss	$-26.28M	$-27.72M	$-24.98M
Cost of Revenue
Net Cash Flow	$-3.73M	$-5.55M	$17.51M
PE Ratio

Splits
Jun 05, 2019	1:10
Nov 21, 2013	1:50
Feb 09, 2007	1:10
Apr 05, 2005	1:20